Profound Medical Corp. provided earnings guidance for full-year 2024. For the period, company expects total revenue to be in the range of $11.0 million to $12.0 million, which represents 53% to 67% growth compared to its prior year revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.08 CAD | -0.69% | -9.92% | -9.19% |
05-15 | Transcript : Profound Medical Corp. - Shareholder/Analyst Call | |
05-14 | Sector Update: Health Care Stocks Steady Premarket Tuesday | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.19% | 180M | |
+10.03% | 223B | |
+13.59% | 195B | |
+20.01% | 144B | |
+30.83% | 111B | |
+2.05% | 65.01B | |
+15.38% | 53.02B | |
+3.96% | 50.45B | |
+8.37% | 44.15B | |
+3.27% | 36.45B |
- Stock Market
- Equities
- PRN Stock
- News Profound Medical Corp.
- Profound Medical Corp. Provides Earnings Guidance for Full-Year 2024